This independent educational program was supported by a grant from Abbott Laboratories.     SPECIAL-TOPIC SLIDE SET Available for download:   The What, the Why, and the How of Lipoatrophy in HIV   This special-topic Visionary Health Concepts’ slide set was created to help organizations and healthcare providers present this complicated topic to clients and colleagues in an easy-to-understand format. Includes 55 simple slides filled with illustrations and photographs that are designed to help anyone understand and share current knowledge about fat loss (lipoatrophy) in HIV with others.   Don't forget to place your order for "Lipoatrophy: Fat Loss in HIV" patient pamphlet and poster set.   PRE-PROGRAM SURVEY  (required to download) E-mail:             1) Lipoatrophy (fat loss in face, arms, legs, butt) occurs in men and women       equally:        Yes No   2) Which of the following NRTI medications cause the most fat loss?   d4T (Zerit) and AZT (Retrovir) tenofovir (Viread) and abacavir (Ziagen) emtricitabine (Emtriva) none of the above   3) Please choose the answer that most closely represents following statement:    “Protease inhibitors are not the main cause of fat loss.”    Agree Don’t know Disagree   4) Once a good amount of fat loss has occurred, can the effects be reversed totally     by switching drugs?   No, switching doesn’t work. Yes, a total return to normal is possible. Somewhat, switching can help a little, but the change is not often noticeable. It depends on which drugs are used in the switch.     HOME    VISION, MISSION & VALUES   FREE EDUCATIONAL PROGRAMS   ORGANIZATION REGISTRATION   SITE MAP  PATIENT REGISTRATION    FACULTY    MEET OUR TEAM    VISION, MISSION & VALUES    POLICIES & DISCLAIMERS   CONTACT US